Pharmacy

Your Article Summary

See Latest Articles

U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma Patients Remains on FDA Hold
BioPure, 08/04/09

Biopure Corporation announced that the Food and Drug Administration has advised the U.S. Naval Medical Research Center by letter that it may not initiate a clinical trial of Biopure's oxygen therapeutic Hemopure under a proposed protocol submitted to the FDA in March 2009. As previously announced, the study, "Restore Effective Survival in Shock" was first proposed and submitted to the FDA in 2005. The proposed trial was placed on clinical hold at that time.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09

Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09

Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial
Nephrology Dialysis Transplantation, 12/08/09

 See all of Drug Trials

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09

Inflammatory breast cancer: what are the treatment options
Expert Opinion in Pharmacotherapy, 12/08/09

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Expert Opinion on Investigational Drugs, 12/08/09

 See all of Other Drugs